Results 171 to 180 of about 6,828 (196)
Some of the next articles are maybe not open access.
Ophthalmology Glaucoma, 2020
PURPOSE To evaluate the effectiveness and safety of primary and adjunctive micropulse cyclophotocoagulation (MPCPC) in the treatment of ocular hypertension (OHT) and glaucoma. DESIGN Retrospective cohort study.
Qayim Kaba +3 more
semanticscholar +1 more source
PURPOSE To evaluate the effectiveness and safety of primary and adjunctive micropulse cyclophotocoagulation (MPCPC) in the treatment of ocular hypertension (OHT) and glaucoma. DESIGN Retrospective cohort study.
Qayim Kaba +3 more
semanticscholar +1 more source
Micropulse cyclophotocoagulation in the treatment of refractory glaucoma in children
O. A. Konikova, O. V. Diskalenko
semanticscholar +2 more sources
Modern technologies in ophtalmology, 2023
Purpose. To evaluate clinical efficacy and safety of micropulse cyclophotocoagulation (MP-CPC) in treatment patients with advanced and severe stages of primary open-angle glaucoma (POAG). Material and methods.
A. V. Postupaev, N. V. Postupaeva
semanticscholar +1 more source
Purpose. To evaluate clinical efficacy and safety of micropulse cyclophotocoagulation (MP-CPC) in treatment patients with advanced and severe stages of primary open-angle glaucoma (POAG). Material and methods.
A. V. Postupaev, N. V. Postupaeva
semanticscholar +1 more source
Micropulse Trans-Scleral Cyclophotocoagulation (mTSCPC)
2017Traditional cyclophotocoagulation has typically been reserved for patients with poor vision and end-stage glaucoma, but the use of a safer micropulse technique has allowed the expansion of this treatment option to patients with moderate and/or severe glaucoma.
Nathan M Radcliffe
exaly +2 more sources
Efficacy and Safety of Micropulse® Transscleral Cyclophotocoagulation in Glaucoma
Archivos De La Sociedad Espanola De Oftalmologia, 2018To report the results using Micropulse® transscleral cyclophotocoagulation (Iridex) in the treatment of glaucoma.Retrospective study in adult patients with glaucoma with at least 6 months of follow-up, and only one session of Micropulse®. The same surgical technique was used in all cases. The only laser parameter that could vary was the total treatment
F G, Sanchez +6 more
exaly +3 more sources
Journal of glaucoma
PRÉCIS SC-TSCPC significantly lowers intraocular pressure more effectively than MP-TSCPC and performs similarly to CW-TSCPC. Safety and visual outcomes are comparable, supporting its use as a non-incisional treatment option for various glaucoma patients.
N. Narainswami +8 more
semanticscholar +1 more source
PRÉCIS SC-TSCPC significantly lowers intraocular pressure more effectively than MP-TSCPC and performs similarly to CW-TSCPC. Safety and visual outcomes are comparable, supporting its use as a non-incisional treatment option for various glaucoma patients.
N. Narainswami +8 more
semanticscholar +1 more source
Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma
European Journal of Ophthalmology, 2019Purpose: To describe our clinical experience with the efficacy and safety of micropulse transscleral cyclophotocoagulation as a treatment for glaucoma. Methods: In this retrospective case series, we reviewed the charts of 95 ...
Alexander T, Nguyen +2 more
openaire +2 more sources
Modern technologies in ophtalmology
Quite often, the use of silicone oil (SO) in routine vitrectomy can lead to increased IOP. Silicone-induced glaucoma is classified as refractory. It is difficult to treat with hypotensive drops or surgical treatment.
A. О. Martsinkevich +2 more
semanticscholar +1 more source
Quite often, the use of silicone oil (SO) in routine vitrectomy can lead to increased IOP. Silicone-induced glaucoma is classified as refractory. It is difficult to treat with hypotensive drops or surgical treatment.
A. О. Martsinkevich +2 more
semanticscholar +1 more source
Micropulsed diode laser cyclophotocoagulation in recurrent pediatric glaucoma
European Journal of Ophthalmology, 2019Purpose: To evaluate the intermediate-term efficacy and safety of micropulsed diode laser cyclophotocoagulation in recurrent pediatric glaucoma. Patients and Methods: A prospective interventional study included children <16 years ...
Eman M, Elhefney +6 more
openaire +2 more sources
Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma
Lasers in Medical Science, 2015Glaucoma is the leading cause of irreversible blindness worldwide. The goal of this study was to describe our experience with the novel micropulse transscleral cyclophotocoagulation (MP-TSCPC; IRIDEX IQ810 Laser Systems, CA) in patients with advanced glaucoma. Patients with advanced glaucoma who underwent MP-TSCPC were included in our study.
Sarah, Kuchar +3 more
openaire +2 more sources

